SEC Form D · filed January 4, 2024
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Yenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorYongxiang (Sean) Zheng · EMERYVILLE, CADirectorTommy Law · EMERYVILLE, CAExecJustin M. Hall · EMERYVILLE, CAExec · DirectorJulie Garlikov · EMERYVILLE, CADirectorPaul E. Freiman · EMERYVILLE, CADirectorSwan E. Sit · EMERYVILLE, CADirectorMijia (Bob) E. Wu · EMERYVILLE, CADirectorBhavika Vyas · New York, NYDirectorCato Partners GP, LLC · New York, NYDirectorJorge E. Bartolome · Chapel Hill, NCDirectorSamuel Schreiber · Chilmark, MADirectorDax T. Mitchell · Dallas, TXExecWilliam Burns · McKinney, TXExec · DirectorStephen E. Butts · Chapel Hill, NCDirectorJp A. Paquin · New York, NYDirectorCato Partners Management, LLC · New York, NYDirectorSteven M. Diedrich · Waco, TXDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorJeff Siegel · Huntsville, UTExec · DirectorStephen Dalby · Lehi, UTDirectorHugh D. Evans · NEW YORK, NYDirectorVincent A. Levien · Florham Park, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗